Transition report pursuant to Rule 13a-10 or 15d-10

CONSOLIDATED BALANCE SHEET

v2.4.0.8
CONSOLIDATED BALANCE SHEET (USD $)
Aug. 31, 2014
Oct. 31, 2013
Current    
Cash and cash equivalents $ 703,030 $ 65,542
Accounts receivable 97,003 79,217
Assets Held For Sale 1,400,000 0
Prepaid expenses and deposit 367,441 1,507
Total Current Assets 2,567,474 146,266
Assets Held For Sale 0 3,427,086
Medical Marijuana Investments 67,662 0
Total Noncurrent Assets 67,662 3,427,086
TOTAL ASSETS 2,635,136 3,573,352
Current    
Accounts payable and accrued liabilities 93,553 136,273
Loan payable 776,936 1,277,161
Share Subscriptions Received 45,780 0
Due to a related party 1,769 1,769
Total Current Liabilities 918,038 1,415,203
Liabilities Held For Sale 0 59,245
TOTAL LIABILITIES 918,038 1,474,448
STOCKHOLDERS' EQUITY    
Share Capital Authorized: 200,000,000 common voting shares with a par value of $0.001 per share Issued and outstanding: 32,249,690 common shares at August 31, 2014 and 16,431,452 common shares at October 31, 2013 34,247 16,431
Additional paid-in capital 10,033,440 7,140,150
Share to be refund (35,200) 0
Deficit (8,315,389) (5,057,677)
Total Stockholders' Equity 1,717,098 2,098,904
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,635,136 $ 3,573,352